Quick Search
Don't open 50 tabs. Quickly search for all the settlements you're entitled to.
Track Progress
Don't read settlements you've seen. Click Read to record and track which ones you have read through.
Quality Focus
No more tiny settlements. We only publish settlements above $1m total settlement.
Get Paid
Receive your settlement payment once approved.
Featured Investigations
Apple Siri Privacy Settlement - Up to $20 Per Device Compensation Available
Apple has agreed to pay $95 million to settle claims that Siri recorded conversations without consent and potentially shared data with advertisers. Eligible device owners can receive up to $20 per device. The settlement awaits final approval.
Stay Updated
Get the latest investigations and class action settlements delivered straight to your inbox.
Featured Settlements
Similasan Settles $3.5M Class Action Over Deceptive Eye Drop Advertising
Similasan Corporation has agreed to a $3.5M settlement over allegations of deceptively labeling and advertising its eye products as 'homeopathic' without FDA approval. The class action lawsuit covers purchases made from September 11, 2017, through February 20, 2025. Eligible consumers who purchased certain Similasan, CVS, or Walgreens eye drops in the U.S. may receive a payment of $2.50 per product.
Pilgrim's Pride Settles $100M Class Action Over Broiler Chicken Grower Compensation
The $100M settlement is related to a class action lawsuit against Pilgrim's Pride Corporation and other companies. The companies allegedly conspired to artificially reduce the amount paid to broiler chicken growers between January 27, 2013, and December 31, 2019. Farmers who provided 'Broiler Grow-Out Services' are eligible for a payout from the settlement.
$8.75M Settlement in Botanic Tonics Class Action Over Kratom Health Risks Disclosure
Botanic Tonics, LLC has agreed to an $8.75 million settlement over its Feel Free Wellness Tonic with Kratom. The lawsuit claims that the company did not adequately warn consumers about potential health risks of the product between March 28, 2019, and March 5, 2025. Eligible consumers could receive at least $10 per bottle purchased.
Old Lyme Gourmet Settles for $4 Million Over False Non-GMO Advertising Claims for Deep River Chips
Old Lyme Gourmet Co. has agreed to a $4 million settlement over claims that it falsely advertised its Deep River potato chips as non-GMO, despite containing GMO ingredients. The settlement applies to consumers who purchased these chips between February 2, 2017, and December 6, 2024.
Haleon Agrees to $4.5M Settlement Over Misleading Non-Drowsy Robitussin Claims
Haleon has settled a $4.5 million class action lawsuit that alleged false advertising of its Robitussin products as 'non-drowsy' despite containing a potentially drowsy-inducing ingredient. The settlement benefits consumers who bought these products between Feb. 16, 2016, and Jan. 21, 2025.
Fisher-Price Settles $19M Class Action Over Defective Infant Sleeper Causing Injuries and Deaths
A $19M class action settlement has been reached with Mattel, Fisher-Price, and Amazon over the Fisher-Price Rock 'n Play Sleeper, a product found to be defective and dangerous, leading to infant deaths and injuries. The issue occurred from January 1, 2009, until the product recall in April 2019. Eligible are individuals who purchased or acquired the Rock 'n Play Sleeper within the USA, the District of Columbia, Puerto Rico, and all U.S. territories.
Apple Agrees to $95M Settlement in Siri Privacy Breach Class Action Lawsuit
Apple has agreed to a $95M settlement regarding a class action lawsuit about Siri recording private conversations without user consent between September 17, 2014, and December 31, 2024. Eligible individuals include U.S. residents who owned a Siri-enabled device during this period.
CVS Pays $1M Settlement for Selling Eye Drops Produced in Unsanitary Conditions
CVS has agreed to a $1 million settlement over a class action lawsuit due to allegations of selling eye drop products manufactured under unsanitary conditions in India between October 1, 2021, and October 25, 2023. U.S. consumers who purchased the listed CVS-branded eye drops during this period are eligible to claim.